Jeil Pharmaceutical Co.,Ltd (KRX:271980)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,160
+160 (1.14%)
At close: Aug 14, 2025, 3:30 PM KST
-7.33%
Market Cap 204.00B
Revenue (ttm) 697.15B
Net Income (ttm) -24.47B
Shares Out 14.57M
EPS (ttm) -1,679.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,531
Average Volume 13,009
Open 14,150
Previous Close 14,000
Day's Range 14,000 - 14,260
52-Week Range 10,120 - 16,680
Beta 0.84
RSI 48.85
Earnings Date Aug 13, 2025

About KRX:271980

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1959
Employees 943
Stock Exchange Korea Stock Exchange
Ticker Symbol 271980
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.